Business Description
Hualan Biological Bacterin Inc
No. 1, No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Compare
Compare
Traded in other countries / regions
301207.China
Description
Hualan Biological Bacterin Inc is engaged in human vaccine development, production and sales.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.76 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 0.66 | |||||
| Interest Coverage | 58.78 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 9.08 | |||||
| Beneish M-Score | -2.16 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 31.6 | |||||
| 3-Year EBITDA Growth Rate | 27.3 | |||||
| 3-Year EPS without NRI Growth Rate | 32 | |||||
| 3-Year Book Growth Rate | 46.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.83 | |||||
| 9-Day RSI | 64.75 | |||||
| 14-Day RSI | 58.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.74 | |||||
| Quick Ratio | 2.54 | |||||
| Cash Ratio | 1.75 | |||||
| Days Inventory | 376.65 | |||||
| Days Sales Outstanding | 238.93 | |||||
| Days Payable | 308.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.37 | |||||
| Forward Dividend Yield % | 0.37 | |||||
| 5-Year Yield-on-Cost % | 0.37 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 88 | |||||
| Operating Margin % | 45.49 | |||||
| Net Margin % | 34.05 | |||||
| ROE % | 20.93 | |||||
| ROA % | 13.51 | |||||
| ROIC % | 28.21 | |||||
| ROC (Joel Greenblatt) % | 45.52 | |||||
| ROCE % | 21.68 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.15 | |||||
| PE Ratio without NRI | 31.15 | |||||
| Price-to-Owner-Earnings | 67.44 | |||||
| PS Ratio | 10.62 | |||||
| PB Ratio | 4.28 | |||||
| Price-to-Tangible-Book | 4.32 | |||||
| Price-to-Operating-Cash-Flow | 70.65 | |||||
| EV-to-EBIT | 26.59 | |||||
| EV-to-EBITDA | 25.27 | |||||
| EV-to-Revenue | 10.49 | |||||
| EV-to-FCF | -89.05 | |||||
| Price-to-Graham-Number | 2.44 | |||||
| Price-to-Net-Current-Asset-Value | 7.64 | |||||
| Price-to-Net-Cash | 18.08 | |||||
| Earnings Yield (Greenblatt) % | 3.76 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,833.405 | ||
| EPS (TTM) (¥) | 1.735 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 58.33 | ||
| 14-Day ATR (¥) | 2.310736 | ||
| 20-Day SMA (¥) | 50.7195 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (¥) | 38.89 - 79.78 | ||
| Shares Outstanding (Mil) | 400.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hualan Biological Bacterin Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||